In vivo brain 31P‐MRS: measuring the phospholipid resonances at 4 Tesla from small voxels
- 1 August 2002
- journal article
- research article
- Published by Wiley in NMR in Biomedicine
- Vol. 15 (5) , 338-347
Abstract
An optimized phosphorous (31P) three‐dimensional chemical‐shift imaging (3D‐CSI) protocol was developed at 4 T to study the phospholipid metabolism from discrete regions in the human brain without the need for 1H‐decoupling or nuclear Overhauser enhancement (NOE). In this study, a spherically bound, weighted average, random point omission 3D‐CSI technique was developed and tested, based on methods proposed in the literature. The technique yields a significant (p < 0.001, two‐tailed, 5% confidence level) increase in signal‐to‐noise (SNR) efficiency over conventional 3D‐CSI (phantom 32%), without an increase in voxel bleedthrough. An automated time‐domain fitting procedure utilizing prior spectral knowledge quantified the individual brain phospholipid metabolites from 15 cm3 effective (8.0 cm3 nominal) volumes from the left/right‐parieto‐occipital cortex and left/right thalamus in 10 normal volunteers. Individual constituents from the phosphomonoester (PME) region; phosphoethanolamine (PEth), phosphocholine (PCh) and the phosphodiester (PDE) region; glycerophosphoethanolamine (GPEth), glycerophosphocholine (GPCh) and membrane phospholipids (MP) were separately quantified to assess the precision of our method at 4 T against previous 1H‐decoupled 31P‐MRS brain studies at lower fields and much larger voxels. Derived concentrations (mM/l tissue) for PEth, PCh, GPEth, GPCh and MP in the left‐parieto‐occipital cortex were 0.81 ± 0.21, 0.46 ± 0.14, 0.74 ± 0.30, 1.15 ± 0.43 and 1.54 ± 0.95 mM, respectively, and 0.94 ± 0.16, 0.46 ± 0.17, 0.83 ± 0.22, 1.14 ± 0.40 and 1.26 ± 0.78 mM for the right parieto‐occipital cortex. Derived concentrations (mM/l tissue) for PEth, PCh, GPEth, GPCh and MP in the left‐thalamus were 0.69 ± 0.18, 0.42 ± 0.16, 0.63 ± 0.20, 1.05 ± 0.42 and 0.93 ± 0.56 mM, respectively, and 0.68 ± 0.24, 0.34 ± 0.18, 0.60 ± 0.23, 1.09 ± 0.36 and 0.74 ± 0.48 mM for the right‐thalamus. This is the first study to our knowledge that has been able to quantify each of these individual phospholipid metabolites from such small voxels in the brain within a clinically reasonable scan time and without 1H‐decoupling or NOE. Copyright © 2002 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Improvements on an in Vivo automatic shimming method (FASTERMAP)Magnetic Resonance in Medicine, 1997
- Cortical Development and Thalamic Pathology in SchizophreniaSchizophrenia Bulletin, 1997
- Assessment of absolute metabolite concentrations in human tissue by31P MRS invivo. Part I: Cerebrum, cerebellum, cerebral gray and white matterMagnetic Resonance in Medicine, 1994
- Investigation of broad resonances in 31P NMR spectra of the human brain in vivoNMR in Biomedicine, 1994
- Automatic, localized in Vivo adjustment of all first‐and second‐order shim coilsMagnetic Resonance in Medicine, 1993
- Analysis of phospholipids in brain tissue by 31P NMR at different compositions of the solvent system chloroform‐methanol‐ waterMagnetic Resonance in Medicine, 1992
- 31P-NMR study of brain phospholipid structures in vivoBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Noninvasive quantitation of phosphorus metabolites in human tissue by NMR spectroscopyJournal of Magnetic Resonance (1969), 1989
- Chemical characterization of a prominent phosphomonoester resonance from mammalian brain. 31P and 1H NMR analysis at 4.7 and 14.1 teslaJournal of Magnetic Resonance (1969), 1986
- High-resolution magnetic resonance spectra from a sensitive region defined with pulsed field gradientsJournal of Magnetic Resonance (1969), 1984